ATG4B
MOLECULAR TARGETautophagy related 4B cysteine peptidase
ATG4B (autophagy related 4B cysteine peptidase) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ATG4B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Aurintricarboxylic Acid | 1.61 | 4 |
| 2 | alpha-Linolenic Acid | 1.39 | 3 |
| 3 | Ethylmaleimide | 1.39 | 3 |
| 4 | Iodoacetamide | 1.10 | 2 |
| 5 | Thyroxine | 0.69 | 1 |
| 6 | Hexachlorophene | 0.69 | 1 |
| 7 | streptonigrin | 0.69 | 1 |
| 8 | Thyroxine | 0.69 | 1 |
About ATG4B as a Drug Target
ATG4B (autophagy related 4B cysteine peptidase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented ATG4B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ATG4B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.